Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
13F holders, Q2 2025
Institutional positions in Titan Pharmaceuticals Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +3 vs. Q1 2025
- Shares held
- 37.7K
- +23.0K (+156.2%) vs. Q1 2025
- Total value
- $158.3K
- +$106.4K (+204.8%) vs. Q1 2025
- New holders
- 3
- 2 more added
- Sold out
- 0
- 2 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TTNP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $69 |
| Q1 2026 | 6 | $130 |
| Q4 2025 | 4 | $154 |
| Q3 2025 | 18 | $107.1K |
| Q2 2025 | 20 | $158.3K |
| Q1 2025 | 17 | $51.9K |
| Q4 2024 | 15 | $9.41K |
| Q3 2024 | 16 | $88.5K |
| Q2 2024 | 18 | $179.3K |
| Q1 2024 | 17 | $230.0K |
| Q4 2023 | 24 | $408.2K |
| Q3 2023 | 27 | $497.8K |
| Q2 2023 | 25 | $632.7K |
| Q1 2023 | 22 | $787.4K |
| Q4 2022 | 23 | $757.9K |
| Q3 2022 | 21 | $1.14M |
| Q2 2022 | 24 | $371.0K |
| Q1 2022 | 24 | $1.24M |
| Q4 2021 | 24 | $430.0K |
| Q3 2021 | 22 | $722.0K |
| Q2 2021 | 23 | $1.51M |
| Q1 2021 | 24 | $988.1K |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Titan Pharmaceuticals Inc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 12,069 | $50.7K | 0.00% | +108+0.9% | Added |
| Renaissance Technologies LLC | 11,380 | $47.8K | 0.00% | +11,380 | New |
| Marex Group plc | 10,663 | $44.8K | 0.00% | +10,663 | New |
| UBS Group AG | 3,427 | $14.4K | 0.00% | +833+32.1% | Added |
| CoreCap Advisors, LLC | 88 | $370 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 18 | $75 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 12 | $50 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 10 | $40 | 0.00% | −5−33.3% | Reduced |
| BlackRock, Inc. | 6 | $25 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2 | $8 | 0.00% | −2−50.0% | Reduced |
| Global Wealth Strategies & Associates | 2 | $8 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1 | $4 | 0.00% | 00.0% | Unchanged |
| Caldwell Sutter Capital, Inc. | 1 | $4 | 0.00% | 00.0% | Unchanged |
| St Germain D J Co Inc | 1 | $4 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 1 | $4 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 1 | $4 | 0.00% | 00.0% | Unchanged |
| Cape Investment Advisory, Inc. | 1 | $4 | 0.00% | 00.0% | Unchanged |
| Nemes Rush Group LLC | 1 | $4 | 0.00% | 00.0% | Unchanged |
| Ransom Advisory, Ltd | 1 | $4 | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 1 | $4 | 0.00% | +1 | New |